- People
- Offices
- Capabilities
back- Capabilities
- Corporate, Finance and Investments
- back
- Corporate, Finance and Investments
- Overview
- Activist Defense
- Capital Markets
- Construction and Procurement
- Corporate Governance
- Emerging Companies and Venture Capital
- Employee Benefits and Executive Compensation
- Energy and Infrastructure Projects
- Financial Restructuring
- Fund Finance
- Global Human Capital and Compliance
- Investment Funds and Asset Management
- Leveraged Finance
- Mergers and Acquisitions (M&A)
- Middle East and Islamic Finance and Investment
- Private Equity
- Public Companies
- Real Estate
- Structured Finance and Securitization
- Tax
- Technology Transactions
- Government Matters
- back
- Government Matters
- Overview
- Antitrust
- Data, Privacy and Security
- Environmental, Health and Safety
- FDA and Life Sciences
- Government Advocacy and Public Policy
- Government Contracts
- Healthcare
- Innovation Protection
- International Trade
- National Security and Corporate Espionage
- Securities Enforcement and Regulation
- Special Matters and Government Investigations
- Trial and Global Disputes
- back
- Trial and Global Disputes
- Overview
- Antitrust
- Appellate, Constitutional and Administrative Law
- Bankruptcy and Insolvency Litigation
- Class Action Defense
- Commercial Litigation
- Construction and Engineering Disputes
- Corporate and Securities Litigation
- E-Discovery
- Innovation Protection
- Intellectual Property
- International Arbitration and Litigation
- Labor and Employment
- Product Liability
- Professional Liability
- Toxic & Environmental Torts
- Industries / Issues
- back
- Industries / Issues
- Automotive, Transportation and Mobility
- Energy Transition
- Energy
- Financial Services
- Food and Beverage
- Higher Education
- Life Sciences and Healthcare
- Technology
- Artificial Intelligence (AI) and Machine Learning
- Buy American
- Crisis Management
- Doing Business in Latin America
- Environmental Agenda
- Environmental, Social and Governance (ESG)
- Focus on Women's Health
- Russia/Ukraine
- Special Purpose Acquisition Companies (SPACs)
- Careers
- News & Insights
- About
- Languages
Thomas J. Spulak
News 22 results
Recognition
June 11, 2025
King & Spalding Earns Top-Tier Rankings in Legal 500 United States 2025 Guide
Recognition
June 5, 2025
King & Spalding Earns 209 Lawyer Rankings, 100 Practice Group Rankings in Chambers USA Guide
In the News · Source: POLITICO Pro Influence
February 7, 2025
Tom Spulak explains why Senate Judiciary Chair Chuck Grassley has consistently sought greater enforcement and fewer exceptions to FARA
In the News · Source: Politico
June 18, 2024
Tom Spulak discusses the impact of lobbying firms dumping Chinese clients in response to a recent report
Events 28 results
Conference
March 17, 2025
34th Annual King & Spalding Health Law & Policy Forum
Speaking Engagement
January 30, 2025
Thomas Spulak, Cal Smith, and Peter Wozniak to Speak at the National Associate of Corporate Directors
Speaking Engagement
December 6, 2024
Tom Spulak to Speak at the FARA Conference
Conference
September 30, 2024
Annual Health Law & Policy Forum West
Insights 46 results
Client Alert
February 20, 2025
Despite Reduced Investigative Authority, Congressional Democrats Ramp Up Trump Administration Oversight
Client Alert
February 13, 2025
Trump’s DOJ Rolls Back Enforcement of the Foreign Agents Registration Act
Client Alert
January 15, 2025
119th Congress House Rules – Key Oversight Provisions
Client Alert
January 6, 2025
Proposed Changes to FARA Will Result in More Questions than Answers